0001709215-17-000001.txt : 20170614
0001709215-17-000001.hdr.sgml : 20170614
20170614150503
ACCESSION NUMBER: 0001709215-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20170614
DATE AS OF CHANGE: 20170614
EFFECTIVENESS DATE: 20170614
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cycle Venture Partners Fund I, L.P. - Cybrexa Series
CENTRAL INDEX KEY: 0001709215
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-288738
FILM NUMBER: 17911018
BUSINESS ADDRESS:
STREET 1: 50 LIMEWOOD AVENUE
CITY: BRANDORD
STATE: CT
ZIP: 06405
BUSINESS PHONE: 203-994-0290
MAIL ADDRESS:
STREET 1: 50 LIMEWOOD AVENUE
CITY: BRANDORD
STATE: CT
ZIP: 06405
D
1
primary_doc.xml
X0707
D
LIVE
0001709215
Cycle Venture Partners Fund I, L.P. - Cybrexa Series
50 LIMEWOOD AVENUE
BRANFORD
CT
CONNECTICUT
06405
203-994-0290
DELAWARE
None
None
Other
Series Limited Partnership
true
2017
SAME
Cycle Venture Partners GP LLC
50 Limewood Avenue
Branford
CT
CONNECTICUT
06405
Executive Officer
General Partner
F.
Kevin
Didden
c/o Cycle Venture Partners GP LLC
50 Limewood Avenue
Branford
CT
CONNECTICUT
06405
Executive Officer
Member of General Partner of Issuer
Michael
Grillo
c/o Cycle Venture Partners GP LLC
50 Limewood Avenue
Branford
CT
CONNECTICUT
06405
Executive Officer
Member of General Partner of Issuer
Alan
D.
Kersey
c/o Cycle Venture Partners GP LLC
50 Limewood Avenue
Branford
CT
CONNECTICUT
06405
Executive Officer
Member of General Partner of Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
false
2017-05-31
true
true
true
false
100000
Indefinite
2100000
Indefinite
Subject to the discretion of the General Partner to accept investment amounts of less than $100,000.
false
6
0
0
0
The Investment Manager or an affiliate receives expense pass through expenses and a special allocation of a percentage of annual net profits.
false
Cycle Venture Partners Fund I, L.P. - Cybrexa Series
/s/ F. Kevin Didden
F. Kevin Didden
President
2017-06-14